Endocan of the maternal placenta tissue is increased in pre-eclampsia

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 11, 2015, Pages 14733-14740

  Chang, Xinwen ^a   Bian, Yiding ^a   Wu, Yanming ^a   Huang, Yajing ^a   Wang, Kai ^a   Duan, Tao ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Endocan; Endothelial dysfunction; Pre eclampsia; Vascular inflammation

Indexed keywords

BIOLOGICAL MARKER; ESM1 PROTEIN, HUMAN; PROTEOGLYCAN; TUMOR PROTEIN;

ADULT; BIOSYNTHESIS; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PLACENTA; PREECLAMPSIA; PREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THIRD TRIMESTER PREGNANCY; WESTERN BLOTTING;

ADULT; BIOMARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84991695160     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Brennan LJ, Morton JS and Davidge ST. Vascular dysfunction in preeclampsia. Microcirculation 2014; 21: 4-14
2. Steegers EA, von Dadelszen P, Duvekot JJ and Pijnenborg R. Pre-eclampsia. Lancet 2010; 376: 631-644
3. Khan KS, Wojdyla D, Say L, Gulmezoglu AM and Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-1074
4. Naderi M, Yaghootkar H, Tara F, Tavakkol Afshari J, Farid Hosseini R, Ghayour Mobarhan M, Shapouri Moghadam A, Mirteimouri M and Tara SM. Tumor necrosis factor-alpha polymorphism at position-238 in preeclampsia. Iran Red Crescent Med J 2014; 16: e11195
5. Shenoy V, Kanasaki K and Kalluri R. Pre-eclampsia: connecting angiogenic and metabolic pathways. Trends Endocrin Met 2010; 21: 529-536
6. Perez-Sepulveda A, Espana-Perrot PP, Norwitz ER and Illanes SE. Metabolic Pathways Involved in 2-Methoxyestradiol Synthesis and Their Role in Preeclampsia. Reprod Sci 2013; 20: 1020-1029
7. Chaiworapongsa T, Chaemsaithong P, Yeo L and Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 2014; 10: 466-480
8. Powe CE, Levine RJ and Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123: 2856-2869
9. Borzychowski AM, Sargent IL and Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006; 11: 309-316
10. Eiland E, Nzerue C and Faulkner M. Preeclampsia 2012. J Pregnancy 2012; 2012: 586578
11. Bechard D, Meignin V, Scherpereel A, Oudin S, Kervoaze G, Bertheau P, Janin A, Tonnel A and Lassalle P. Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res 2000; 37: 417-425
12. Pawlak K, Mysliwiec M and Pawlak D. Endocan-the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease. Clin Biochem 2015; 48: 425-30
13. Aparci M, Isilak Z, Uz O, Yalcin M and Kucuk U. Endocan and Endothelial Dysfunction. Angiology 2015; 66: 488-9
14. Bechard D, Gentina T, Delehedde M, Scherpereel A, Lyon M, Aumercier M, Vazeux R, Richet C, Degand P, Jude B, Janin A, Fernig DG, Tonnel AB and Lassalle P. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem 2001; 276: 48341-48349
15. Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Kurtoglu E, Demir M, Celik T, Turker T and Iyisoy A. Endocan-A Novel Inflammatory Indicator in Newly Diagnosed Patients With Hypertension: A Pilot Study. Angiology 2014; 65: 773-7
16. Grigoriu BD, Depontieu F, Scherpereel A, Gourcerol D, Devos P, Ouatas T, Lafitte JJ, Copin MC, Tonnel AB and Lassalle P. Endocan expression and relationship with survival in human non-small cell lung cancer. Clin Cancer Res 2006; 12: 4575-4582
17. Zuo L, Zhang SM, Hu RL, Zhu HQ, Zhou Q, Gui SY, Wu Q and Wang Y. Correlation between expression and differentiation of endocan in colorectal cancer. World J Gastroenterol 2008; 14: 4562-4568
18. Huang GW, Tao YM and Ding X. Endocan expression correlated with poor survival in human hepatocellular carcinoma. Dig Dis Sci 2009; 54: 389-394
19. Paulus P, Jennewein C and Zacharowski K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers 2011; 16 Suppl 1: S11-21
20. Hentschke MR, Lucas LS, Mistry HD, Pinheiro da Costa BE and Poli-de-Figueiredo CE. Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy. Cytokine 2015; 74: 152-156
21. Adekola H, Romero R, Chaemsaithong P, Korzeniewski SJ, Dong Z, Yeo L, Hassan SS and Chaiworapongsa T. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med 2015; 28: 1621-1632
22. Yuksel MA, Tuten A, Oncul M, Acikgoz AS, Yuksel IT, Toprak MS, Ekmekci H, Ekmekci OB and Madazli R. Serum endocan concentration in women with pre-eclampsia. Archives of gynecology and obstetrics 2015; 292: 69-73
23. Obstetricians ACo and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin 2002; 33: 159-167
24. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA and McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-1204
25. Pereira RD, De Long NE, Wang RC, Yazdi FT, Holloway AC and Raha S. Angiogenesis in the placenta: the role of reactive oxygen species signaling. Biomed Res Int 2015; 2015: 814543
26. Bechard D, Meignin V, ronique e, Scherpereel A, Oudin S, Kervoaze G, Bertheau P, Janin A, Tonnel AB and Lassalle P. Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res 2000; 37: 417-425
27. Delehedde M, Devenyns L, Maurage CA and Vivès RR. Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol 2013; 2013: 705027
28. Redman CW and Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308: 1592-1594
29. Shin JW, Huggenberger R and Detmar M. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Blood 2008; 112: 2318-2326
30. Rennel E, Mellberg S, Dimberg A, Petersson L, Botling J, Ameur A, Westholm JO, Komorowski J, Lassalle P and Cross MJ. Endocan is a VEGFA and PI3K regulated gene with increased expression in human renal cancer. Exp Cell Res 2007; 313: 1285-1294
31. Sargent IL, Borzychowski AM and Redman CW. NK cells and human pregnancy-an inflammatory view. Trends Immunol 2006; 27: 399-404